Advances in Breast Cancer Management and Extracellular Vesicle Research, a Bibliometric Analysis.
bibliometrics
breast cancer
exosomes
extracellular vesicles
metastasis
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
08 11 2021
08 11 2021
Historique:
received:
12
10
2021
revised:
01
11
2021
accepted:
04
11
2021
entrez:
13
12
2021
pubmed:
14
12
2021
medline:
24
3
2022
Statut:
epublish
Résumé
Extracellular vesicles transport variable content and have crucial functions in cell-cell communication. The role of extracellular vesicles in cancer is a current hot topic, and no bibliometric study has ever analyzed research production regarding their role in breast cancer and indicated the trends in the field. In this way, we aimed to investigate the trends in breast cancer management involved with extracellular vesicle research. Articles were retrieved from Scopus, including all the documents published concerning breast cancer and extracellular vesicles. We analyzed authors, journals, citations, affiliations, and keywords, besides other bibliometric analyses, using R Studio version 3.6.2. and VOSviewer version 1.6.0. A total of 1151 articles were retrieved, and as the main result, our analysis revealed trending topics on biomarkers of liquid biopsy, drug delivery, chemotherapy, autophagy, and microRNA. Additionally, research related to extracellular vesicles in breast cancer has been focused on diagnosis, treatment, and mechanisms of action of breast tumor-derived vesicles. Future studies are expected to explore the role of extracellular vesicles on autophagy and microRNA, besides investigating the application of extracellular vesicles from liquid biopsies for biomarkers and drug delivery, enabling the development and validation of therapeutic strategies for specific cancers.
Identifiants
pubmed: 34898576
pii: curroncol28060382
doi: 10.3390/curroncol28060382
pmc: PMC8628791
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
4504-4520Subventions
Organisme : São Paulo Research Foundation
ID : #2019/02774-0
Organisme : National Council for Scientific and Technological Development
ID : #406683/2018-2
Références
World Neurosurg. 2020 Apr;136:270-282
pubmed: 31953095
Gynecol Oncol. 2011 Aug;122(2):437-46
pubmed: 21601258
Acta Cytol. 2019;63(6):449-455
pubmed: 31091522
Acta Pharm Sin B. 2015 Sep;5(5):402-18
pubmed: 26579471
Int J Mol Sci. 2020 Apr 08;21(7):
pubmed: 32276321
Cancer Cell. 2014 Nov 10;26(5):707-21
pubmed: 25446899
Cancer Lett. 2016 Sep 28;380(1):281-8
pubmed: 26577808
Lancet. 2016 Oct 8;388(10053):1659-1724
pubmed: 27733284
J Nanobiotechnology. 2020 Apr 28;18(1):65
pubmed: 32345308
Annu Rev Cell Dev Biol. 2014;30:255-89
pubmed: 25288114
Nature. 2020 Apr;580(7801):130-135
pubmed: 32238926
Int J Nurs Pract. 2020 Jun;26(3):e12845
pubmed: 32406145
Cell. 2012 Dec 21;151(7):1542-56
pubmed: 23260141
Cancer Sci. 2010 Oct;101(10):2087-92
pubmed: 20624164
Dev Cell. 2018 Apr 9;45(1):33-52.e12
pubmed: 29634935
Arch Med Res. 2013 Apr;44(3):208-14
pubmed: 23506723
BMC Infect Dis. 2020 Aug 1;20(1):561
pubmed: 32738881
Tumour Biol. 2014 Oct;35(10):9649-59
pubmed: 24969560
Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165880
pubmed: 32592936
Int Immunopharmacol. 2019 Jul;72:374-384
pubmed: 31030093
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Int J Environ Res Public Health. 2020 Mar 20;17(6):
pubmed: 32245065
Int J Mol Sci. 2013 Jul 09;14(7):14240-69
pubmed: 23839094
Int J Nanomedicine. 2018 Apr 17;13:2321-2336
pubmed: 29713164
Mol Cancer. 2014 Nov 26;13:256
pubmed: 25428807
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Cells. 2019 Dec 06;8(12):
pubmed: 31817583
Oncotarget. 2016 Aug 2;7(31):49998-50016
pubmed: 27374178
Cancer Gene Ther. 2021 Jun;28(6):634-648
pubmed: 33154575
Scientometrics. 2015;105(3):1809-1831
pubmed: 26594073
PLoS One. 2013 Dec 31;8(12):e84256
pubmed: 24391924
Semin Cell Dev Biol. 2015 Apr;40:60-71
pubmed: 25721809
Int J Oncol. 2012 Jan;40(1):130-8
pubmed: 21904773
Cancer Cell. 2014 Apr 14;25(4):501-15
pubmed: 24735924
J Natl Cancer Inst. 2018 Aug 1;110(8):815-824
pubmed: 29982543
J Cell Sci. 2018 Aug 3;131(15):
pubmed: 30076239
Int J Mol Sci. 2019 May 26;20(10):
pubmed: 31130715
Oncotarget. 2014 Oct 30;5(20):9650-63
pubmed: 25333260
Oncotarget. 2017 Mar 21;8(12):19592-19608
pubmed: 28121625
Mol Cancer. 2011 Sep 22;10:117
pubmed: 21939504
J Bus Res. 2020 Sep;118:253-261
pubmed: 32834211
Nat Cell Biol. 2019 Feb;21(2):190-202
pubmed: 30598531
Crit Rev Oncol Hematol. 2016 Jan;97:303-11
pubmed: 26467073
Nat Rev Cancer. 2020 Mar;20(3):174-186
pubmed: 31980749
J Cancer Res Clin Oncol. 2018 Mar;144(3):415-430
pubmed: 29288363
Cancer Growth Metastasis. 2015 Nov 29;8:43-9
pubmed: 26640389
Sci Signal. 2014 Jul 01;7(332):ra63
pubmed: 24985346
J Biol Chem. 2013 Apr 12;288(15):10849-59
pubmed: 23439645
Nat Cell Biol. 2015 Feb;17(2):183-94
pubmed: 25621950
J Neuroimmune Pharmacol. 2020 Sep;15(3):487-500
pubmed: 31722094
Biomaterials. 2014 Feb;35(7):2383-90
pubmed: 24345736
Chin J Cancer. 2017 Apr 3;36(1):38
pubmed: 28372569
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Clin Oral Investig. 2020 Jan;24(1):447-454
pubmed: 31111281
Eur J Cancer. 2013 May;49(8):1845-59
pubmed: 23453937
J Cell Physiol. 2012 Feb;227(2):658-67
pubmed: 21465472
Transl Res. 2020 Sep;223:40-60
pubmed: 32413499
Lancet. 2017 Mar 18;389(10074):1134-1150
pubmed: 27865536
Proc Natl Acad Sci U S A. 1970 Nov;67(3):1608-15
pubmed: 5274483
Nature. 2015 Jul 9;523(7559):177-82
pubmed: 26106858
Nat Rev Clin Oncol. 2017 Sep;14(9):531-548
pubmed: 28252003
Breast. 2019 Jun;45:61-63
pubmed: 30878882
Nat Commun. 2015 Apr 01;6:6716
pubmed: 25828099
Cell. 2020 Aug 20;182(4):1044-1061.e18
pubmed: 32795414
Cancer Res. 2017 Apr 15;77(8):1927-1941
pubmed: 28202520
Cancers (Basel). 2020 Jun 02;12(6):
pubmed: 32498257
BMC Cancer. 2012 Sep 24;12:421
pubmed: 22998595
Clin Exp Med. 2021 May;21(2):181-194
pubmed: 32266495
Nat Rev Cancer. 2017 May;17(5):302-317
pubmed: 28303905
J Nanobiotechnology. 2019 Sep 3;17(1):93
pubmed: 31481080
Breast Cancer Res. 2020 Jan 28;22(1):11
pubmed: 31992335
Mutat Res. 2011 Jul-Oct;728(1-2):23-34
pubmed: 21605699
Leukemia. 2006 Sep;20(9):1487-95
pubmed: 16791265
Cancer Res. 2019 Apr 15;79(8):1719-1729
pubmed: 30952630
Breast Cancer Res. 2016 Sep 08;18(1):90
pubmed: 27608715
Int J Mol Sci. 2018 Nov 05;19(11):
pubmed: 30400561
Mol Ther. 2013 Jan;21(1):185-91
pubmed: 23032975
Cancer Res. 2013 Dec 1;73(23):6843-7
pubmed: 24265274
Trends Cancer. 2020 Aug;6(8):660-676
pubmed: 32417182